(Q40662519)

English

High susceptibility of human leukemic cells to Fas-induced apoptosis is restricted to G1 phase of the cell cycle and can be increased by interferon treatment

scientific article published on March 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

High susceptibility of human leukemic cells to Fas-induced apoptosis is restricted to G1 phase of the cell cycle and can be increased by interferon treatment (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

1 reference

based on heuristic

inferred from title

author name string

Jedema I

1

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Barge RM

2

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Willemze R

3

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Falkenburg JH

4

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

publication date

1 March 2003

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

576-584

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402844

0 references

Mechanism of action of antitumor drug etoposide: a review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402844

21 January 2018

T cells recognizing leukemic CD34(+) progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402844

21 January 2018

Cell death induced by the Fas/Fas ligand pathway and its role in pathology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402844

21 January 2018

Apoptosis control by death and decoy receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402844

21 January 2018

Apoptosis by death factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402844

21 January 2018

Cell cycle specificity of Fas-mediated apoptosis in WIL-2 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402844

21 January 2018

Interferon in oncological practice: review of interferon biology, clinical applications, and toxicities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402844

21 January 2018

Cytokine therapy for hematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402844

21 January 2018

Flow cytometric multiparameter analysis of proliferating cell nuclear antigen/cyclin and Ki-67 antigen: a new view of the cell cycle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402844

21 January 2018

Differential involvement of caspases in apoptosis of myeloid leukemic cells induced by chemotherapy versus growth factor withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402844

21 January 2018

Positivity of the proliferation marker Ki-67 in noncycling cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402844

21 January 2018

Donor lymphocyte infusion for the treatment of relapse after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402844

7 January 2021

based on heuristic

inferred from DOI database lookup

CD95-mediated apoptosis: no variation in cellular sensitivity during cell cycle progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402844

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor lymphocyte infusion followed by interferon-alpha plus low dose cyclosporine A for modulation of donor CD3 cells activity with monitoring of minimal residual disease and cellular chimerism in a patient with first hematologic relapse of chronic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402844

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of the growth fraction in cell suspensions by flow cytometry using the monoclonal antibody Ki-67

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402844

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2402844

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40662519&oldid=1904287493"